Journals / Ulusal Cerrahi Dergisi / 2010 / Cilt: 26 - Sayı: 4

Removal of a giant hepatic hemangioma by enucleation after selective hepatic artery embolization

Selektif hepatik arter embolizasyonunu takiben, enükleasyon ile çıkarılan dev bir hepatik hemanjiom

Pages
229–232
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient was followed for 13 months without any morbidity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hemangioma is the most common primary tumor of liver.
📊
Key Findings & Data:When the size is larger than 5 cm, it is called a giant hemangioma.
💡
Conclusion & Impact:The patient was followed for 13 months without any morbidity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hemangioma is the most common primary tumor of liver. It is found mostly in a single lobe. When the size is larger than 5 cm, it is called a giant hemangioma. Hemangiomas are usually asymptomatic. Size is not the only criteria when deciding surgery. Indications for surgery are growth of the hemangioma during follow-up, pain, uncertainty in differential diagnosis and spontaneous rupture. Bleeding control during surgery is a major problem. Selective hepatic artery embolization to reduce bleeding alone is effective, but there are not detailed studies about this issue. Studies in the literature are limited to combination of different methods. Our case was a 45 years old postmenopausal patient with abdominal pain who had a successful surgery after embolization. Enucleation was carried out one day after embolization, with minimal bleeding. The patient was followed for 13 months without any morbidity.

Özet

Karaciğerin en sık görülen primer tümörü hemanjiomdur. Çoğunlukla tek sayıda ve tek lobda bulunur. Boyutu 5 cm'den büyük olduğunda dev hemanjiom olarak adlandırılır. Genellikle semptomsuzdur. Boyutunun büyük olması ameliyat kararı için yeterli değildir. Takip esnasında hemanjiomun büyümesi, ağrı şikâyetlerinin olması, ayırıcı tanıdaki belirsizlik ve spontan ruptür ameliyat endikasyonudur. Ameliyat sırasında kanama kontrolü önemli bir sorundur. Kanamayı azaltmak için selektif hepatik arter embolizasyonunun etkili olduğu, ancak tek başına etkinliğinin yetersiz olduğu yönünde çalışmalar vardır. Literatürde cerrahi tedavi yöntemlerinin medikal yöntemlerle kombinasyonuna dair çalışmalar sınırlı sayıdadır. Hemanjiom nedeniyle karın ağrısı olan 45 yaşındaki postmenopozal bir olguda embolizasyon uygulamasını takiben cerrahi tedavinin başarısının arttığı gözlemlendi. Embolizasyon uygulandıktan 1 gün sonra minimal kanama ile enükleasyon ameliyatı yapıldı. Olgu 13 aydır takip edilmektedir. Herhangi bir morbiditesi yoktur.

🔖

Cite This Article

SAKÇAK, İ., AVŞAR, F. M. (2010). Removal of a giant hepatic hemangioma by enucleation after selective hepatic artery embolization. Ulusal Cerrahi Dergisi, Cilt: 26 - Sayı: 4, 229–232. https://ajindex.com/articles/325678

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Ulaş M,Yol S, Bostancı EB, Özoğul Y, et al. Dev karaciğer hemanjiomlarında enükleasyon: 14 Olgu. Ulusal Cerrahi Dergisi 2007;5;21:41-43
  2. Adam YG, Huvos AG, Fortner JG. Giant hemangiomas of the liver. Ann Surg 1970;172:239-245. [DOI:10.1097/00000658- 197008000-00010] 3) Lai HJ, Yu JC, Liu YC, et al. Anterior approach for a symptomatic giant hepatic haemangioma (>30 centimetre). Aust N Z J Surg 2006;76:863-865
  3. Kuo PC, Lewis WD, Jenkins RL. Treatment of giant hemangiomas of the liver by enucleation. J Am Coll Surg 1994; 178:49-53. [DOI:10.1111/j.1445- 2197.2006.03888.x] 5) Gedaly R, Pomposelli JJ, Pomfret EA, et al. Cavernous hemangioma of the liver: anatomic resection vs enucleation. Arch Surg 1999;134:407-411
  4. Gandolfi L, Leo P, Solmi L, et al. Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut 1991; 32: 677- 680. [DOI:10.1136/gut.32.6.677] 7) Tait N, Richardson AJ, Muguti G, et al. Hepatic cavernous haemangioma: A 10 year review. Aust N Z J Surg 1992; 62: 521-514. [DOI:10.1111/j.1445-2197.1992. tb07043.x] 8) Langner C, Thonhofer R, Hegenbarth K, Trauner M. Diffuse hemangiomatosis of the liver and spleen in an adult. Pathology 2001;22:424-428
  5. Berloco P, Bruzzone P, Mennini G, et al. Giant hemangiomas of the liver: Surgical strategies ang technical aspects. HPB 2006;8:200-201
  6. DuPre CT, Fincher RM. Case report: cavernous hemangioma of the liver. Am J Med Sci 1992; 303: 241-244. [DOI:10.1097/00000441-199204000- 00006] 11) Yoshida J, Yamasaki S, Yamamoto J, et al. Growing cavernous haemangioma of the liver: 12-fold increase in volume in a decade. J Gastroenterol Hepatol 1991; 6: 414-416. [DOI:10.1111/j.1440-1746.1991. tb00880.x] 12) Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg 1995; 19:19-24. [DOI:10.1007/ BF00316974] 13) Concejero AM, Chen CL, Chen TY, et al. Giant cavernous hemangioma of the liver with coagulopathy: Adult Kasabach-Meritt syndrome. Surgery 2009;145:245-247. 14) Álvarez Pérez JA, Baldonedo Cernuda RF, Palacios Fernández E. Giant hepatic cavernous hemangioma. Rev Esp Enferm Dig 1994; 85: 403-404
  7. Hamaloglu E, Altun H, Ozdemir A, et al. Giant liver hemangioma: therapy by enucleation or liver resection. World J Surg 2005;29:890-893. [DOI:10.1007/s00268- 005-7661-z] 16) Malagari K, Alexopoulou E, Dourakis S, et al. Transarterial embolization of giant liver hemangiomas associated with Kasabach-Merrit syndrome: a case repo